Published in Gynecol Oncol on April 01, 1999
Costs and effects of abdominal versus laparoscopic hysterectomy: systematic review of controlled trials. PLoS One (2009) 1.05
Laparoscopy or laparotomy for the management of endometrial cancer. JSLS (2005) 0.94
Comparison of laparoscopic versus conventional open surgical staging procedure for endometrial cancer. J Gynecol Oncol (2010) 0.93
The role of laparoscopic staging in the management of patients with early endometrial cancer. Gynecol Oncol (1999) 0.89
Use of Laparoscopy in the Treatment of Endometrial and Cervical Cancer - Results of a 2012 Germany-wide Survey. Geburtshilfe Frauenheilkd (2013) 0.86
Total laparoscopic hysterectomy versus total abdominal hysterectomy: cohort review of patients with uterine neoplasia. JSLS (2005) 0.86
Feasibility and safety of laparoscopic surgery for obese Korean women with endometrial cancer: long-term results at a single institution. J Korean Med Sci (2014) 0.84
Laparoscopic versus abdominal hysterectomy for endometrial cancer: comparison of patient outcomes. Int J Gynecol Cancer (2009) 0.84
Laparoscopic surgery for endometrial cancer: increasing body mass index does not impact postoperative complications. J Gynecol Oncol (2011) 0.83
Laparoscopy or laparotomy? A comparison of 240 patients with early-stage endometrial cancer. Surg Endosc (2009) 0.81
Feasibility, safety, and cost outcomes of laparoscopic management of early endometrial and cervical malignancy. JSLS (2010) 0.80
Laparoscopic pelvic lymphadenectomy in the surgical treatment of endometrial cancer: results of a multicenter study. JSLS (2002) 0.78
Realhand high dexterity instruments for the treatment of stage I uterine malignancy. JSLS (2009) 0.77
Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). PLoS One (2016) 0.75
Comparison of the prognosis and recurrence of apparent early-stage ovarian tumors treated with laparoscopy and laparotomy: a meta-analysis of clinical studies. BMC Cancer (2015) 0.75
Outcomes of laparoscopic fertility-sparing surgery in clinically early-stage epithelial ovarian cancer. J Gynecol Oncol (2016) 0.75
Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA (2000) 3.69
Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol (2002) 3.49
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol (2006) 2.69
A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg (2001) 2.54
Symptoms of ovarian cancer. Obstet Gynecol (2001) 2.27
Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. Clin Cancer Res (1997) 2.03
Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg (1998) 1.69
The contribution of childhood obesity to adult carotid intima-media thickness: the Bogalusa Heart Study. Int J Obes (Lond) (2008) 1.66
Paclitaxel-based chemotherapy in carcinoma of the fallopian tube. Gynecol Oncol (2001) 1.59
Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features. Gynecol Oncol (1994) 1.55
Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potential. Gynecol Oncol (1995) 1.54
High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy. Gynecol Oncol (2001) 1.52
Stage IV ovarian cancer: impact of surgical debulking. Gynecol Oncol (1997) 1.47
Risk of endometrial carcinoma associated with BRCA mutation. Gynecol Oncol (2001) 1.42
Association between initial diagnostic procedure and hysteroscopy and abnormal peritoneal washings in patients with endometrial carcinoma. Cancer (2000) 1.41
Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease. Int J Gynecol Cancer (2007) 1.39
Survival in epithelial ovarian cancer: a multivariate analysis incorporating BRCA mutation status and platinum sensitivity. Ann Oncol (2010) 1.31
The importance of surgical staging in the treatment of malignant pleural mesothelioma. J Thorac Cardiovasc Surg (1996) 1.30
Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer. Cancer Res (1995) 1.29
Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy. J Clin Oncol (2000) 1.19
The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer (2008) 1.18
A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care. Gynecol Oncol (2010) 1.17
High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage. J Natl Cancer Inst (1997) 1.15
Regression of uterine low-grade smooth-muscle tumors metastatic to the lung after oophorectomy. Obstet Gynecol (1997) 1.15
Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes. Gynecol Oncol (2011) 1.12
Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcus. J Thorac Cardiovasc Surg (2000) 1.12
Cervical cancer in pregnancy: reporting on planned delay in therapy. Obstet Gynecol (1993) 1.12
Splenectomy in recurrent epithelial ovarian cancer. Gynecol Oncol (1999) 1.03
A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. J Clin Oncol (1994) 1.02
Hepatic resection for metastatic gynecologic carcinomas. Gynecol Oncol (1997) 1.02
Reproductive outcomes of patients undergoing radical trachelectomy for early-stage cervical cancer. Gynecol Oncol (2012) 1.01
Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive procedures on the detection of stage IIIC endometrial cancer. Gynecol Oncol (2013) 0.99
Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: an updated series. Gynecol Oncol (2010) 0.96
Chest wall resection for locally recurrent breast cancer: is it worthwhile? J Thorac Cardiovasc Surg (2000) 0.96
Initial experience with Dargent's operation: the radical vaginal trachelectomy. Gynecol Oncol (2007) 0.95
Risk factors for recurrence of ovarian borderline tumors. Gynecol Oncol (2010) 0.94
Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings. AJR Am J Roentgenol (1997) 0.93
Modulation of all-trans retinoic acid pharmacokinetics by liarozole. Cancer Chemother Pharmacol (1994) 0.91
Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. Gynecol Oncol (2009) 0.90
Pelvic exenteration for recurrent endometrial cancer. Gynecol Oncol (1999) 0.90
Pap smears in women with endometrial carcinoma. Acta Cytol (2001) 0.89
Molecular genetic analysis of complete hydatidiform moles. Cancer Genet Cytogenet (1991) 0.89
Optimal (≤1 cm) but visible residual disease: is extensive debulking warranted? Gynecol Oncol (2013) 0.89
Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and younger. Gynecol Oncol (2011) 0.88
Gastrointestinal toxicity and Clostridium difficile diarrhea in patients treated with paclitaxel-containing chemotherapy regimens. Gynecol Oncol (1998) 0.87
High-intensity intravenous cyclophosphamide and cisplatin, interim surgical debulking, and intraperitoneal cisplatin in advanced ovarian carcinoma: a pilot trial with ten-year follow-up. Gynecol Oncol (1997) 0.87
The role of surgical cytoreduction in Stage IV endometrial carcinoma. Gynecol Oncol (1997) 0.87
Management of vulvar melanoma. Gynecol Oncol (1992) 0.86
Radical surgical resection and high-dose intraoperative radiation therapy (HDR-IORT) in patients with recurrent gynecologic cancers. Int J Radiat Oncol Biol Phys (2001) 0.86
Salvage weekly paclitaxel in recurrent ovarian cancer. Semin Oncol (1997) 0.85
Ovarian disease in women with breast cancer. Obstet Gynecol (1994) 0.85
Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome. Gynecol Oncol (2012) 0.85
A phase II trial of intraperitoneal cisplatin and etoposide as consolidation therapy in patients with Stage II-IV epithelial ovarian cancer following negative surgical assessment. Gynecol Oncol (1998) 0.85
The role of laparoscopy in second-look evaluations for ovarian cancer. Gynecol Oncol (2001) 0.85
Laparotomy to complete staging of presumed early ovarian cancer. Obstet Gynecol (1996) 0.85
Primary lymphoma of the cervix: MRI findings with gadolinium. Magn Reson Imaging (1991) 0.84
Factors affecting the practice of circumcision. Am J Dis Child (1982) 0.84
Accuracy of frozen section diagnosis of ovarian borderline tumor. Gynecol Oncol (2011) 0.84
Ovarian and uterine disease in women with colorectal cancer. Obstet Gynecol (1997) 0.84
Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix. Gynecol Oncol (1995) 0.83
Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization. Gynecol Oncol (2006) 0.83
Expression of A, B, and H blood group antigens in epithelial ovarian cancer: relationship to tumor grade and patient survival. Gynecol Oncol (1996) 0.83
Distribution of radiolabeled monoclonal antibody MX35 F(ab')2 in tissue samples by storage phosphor screen image analysis: evaluation of antibody localization to micrometastatic disease in epithelial ovarian cancer. Clin Cancer Res (1997) 0.83
ASAS Centennial Paper: Developments and future outlook for preharvest food safety. J Anim Sci (2008) 0.82
Metastatic breast carcinoma to the abdomen and pelvis. Gynecol Oncol (1997) 0.82
Chemotherapy and total parenteral nutrition for advanced ovarian cancer with bowel obstruction. Gynecol Oncol (1997) 0.81
A phase I study evaluating the safety and pharmacokinetics of weekly paclitaxel and carboplatin in relapsed ovarian cancer. Int J Gynecol Cancer (2007) 0.81
Second-look laparotomy in carcinoma of the fallopian tube. Obstet Gynecol (1993) 0.81
Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery. Int J Gynecol Cancer (2007) 0.81
Are more antiemetic trials with a placebo necessary? Report of patient data from randomized trials of placebo antiemetics with cisplatin. Cancer (1996) 0.81
Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study. Gynecol Oncol (1997) 0.81
Twice-daily subcutaneous injection of kisspeptin-54 does not abolish menstrual cyclicity in healthy female volunteers. J Clin Endocrinol Metab (2013) 0.80
The importance of brachytherapy technique in the management of primary carcinoma of the vagina. Int J Radiat Oncol Biol Phys (1992) 0.80
Long-term experience in the surgical management of cancer of the uterine cervix. Semin Surg Oncol (1999) 0.80
Atherosclerotic aortic gangliosides enhance integrin-mediated platelet adhesion to collagen. Arterioscler Thromb Vasc Biol (1999) 0.79
Surgical cytoreduction in stage IV endometrioid endometrial carcinoma. Gynecol Oncol (2011) 0.79
Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer. Gynecol Oncol (2013) 0.78
Resection of recurrent cervical cancer after total pelvic exenteration. Int J Gynecol Cancer (2007) 0.78
Arterial occlusion complicating treatment of gynecologic cancer: a case series. Gynecol Oncol (1996) 0.78
Epithelial ovarian cancer. Curr Probl Surg (1999) 0.78
Epithelial ovarian carcinoma and European birthplace of grandparents. Gynecol Oncol (2001) 0.77
Platinum-based chemotherapy of high-risk stage I epithelial ovarian cancer following comprehensive surgical staging. Obstet Gynecol (1993) 0.77
Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer. J Clin Oncol (1998) 0.77
Second-look operation for epithelial ovarian cancer: laparoscopy or laparotomy? Obstet Gynecol (1996) 0.77
Impact of sentinel lymph node mapping on relative charges in patients with early-stage breast cancer. Ann Surg Oncol (2000) 0.77
Topotecan and liposomal doxorubicin in recurrent ovarian cancer: is sequence important? Int J Gynecol Cancer (2006) 0.77